Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
In the past three months we’ve featured 11 emerging biotech startups — selected from the VentureRadar Database — working on a range new approaches to tackling major diseases. You can find out more about all the companies in the summaries below. Cutanos Cutanos is developing dermal targeted delivery systems for novel vaccines and immunotherapies via […]
Cutanos, a spin-off from the Max Planck Society, is developing dermal targeted delivery systems for novel vaccines and immunotherapies. Delivery of antigens to specialised immune cells, called dendritic cells (DCs), is a promising approach to developing innovative vaccines, as well as immunotherapies against cancer and autoimmune diseases. However, there are different subsets of DCs which […]
NeuVasQ is a spin-off company from the University of Brussels aiming to repair neurovascular function in a range of disorders by restoring the integrity of the blood-brain barrier. The blood-brain barrier (BBB) regulates the exchange between the vascular system and central nervous system (CNS). Increased BBB permeability, due to age or injury, is involved in […]